AixThera is a Dublin, Ireland-based venture capital investor focused on developing new therapeutics that can improve patient lives. The firm backs biotechnology, life sciences and pharmaceutical companies, with early-stage activity including Series A investment in the United Kingdom. Its team includes experienced pharmaceutical operators and executives from Adapt Pharma, Azur Pharma, Jazz Pharmaceuticals and Elan, making it relevant for founders raising venture capital in therapeutics and related biotech areas.